Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Noom vs StaveMD

Noom and StaveMD both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Noom logo

Noom

6.9
★★★★☆3.5/5

Best for: coaching bundled into the price rather than sold separately

Visit Noom →
VS

StaveMD

7.7
★★★★☆3.9/5

Best for: compounded semaglutide or tirzepatide from named pharmacies with a no-weight-loss refund

Visit StaveMD →

If you are choosing between Noom and StaveMD, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. StaveMD leads our six-part score, 7.7 to 6.9.

Noom vs StaveMD price

Noom and StaveMD start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at StaveMD ($249 a month vs $349 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Noom prices compounded injections and brand-name pens, while StaveMD prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.

Where each one treats patients

Noom does not publish where it ships, and StaveMD lists 51 states.

Pricing

Noom

GLP-1Rx Program, compounded semaglutide (medication included)Compounded
$349$149/mo
Save 57% right now
semaglutide

The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.

GLP-1Rx Program — brand tirzepatide (Zepbound/Mounjaro)Brand-name
$349/mo
tirzepatide
Microdose GLP-1Rx, compounded semaglutide (medication included)Compounded
$179$79/mo
Save 56% right now
semaglutide

The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.

StaveMD

Weekly injection, renews every 4 weeksCompounded
$179/mo
semaglutide

Listed as "Starting from $179/mo" with free shipping and no membership fee. Plans renew every four weeks, so there are 13 charges a year; longer plan options are shown only during sign-up.

Oral ODT (daily dissolving tablet), renews every 4 weeksCompounded
$199/mo
semaglutide

Listed as "Starting from $199/mo" for compounded semaglutide as a dissolving tablet.

Weekly injection, renews every 4 weeksCompounded
$249/mo
tirzepatide

Listed as "Starting from $249/mo" for compounded tirzepatide.

What each price covers

Noom's price also covers the clinician visit and coaching, which StaveMD does not claim.

StaveMD's price also covers shipping, which Noom does not claim.

Noom is silent on the medication itself, shipping and lab work.

StaveMD is silent on the clinician visit, the medication itself, lab work and coaching.

Noom

Covered by the monthly price

Medication

Not stated

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

StaveMD

Covered by the monthly price

Medication

Not stated

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, StaveMD scores 7.7 and Noom 6.9 out of 10.

StaveMD is stronger on trust & safety (7.5 vs 6.5), accessibility (10.0 vs 5.0) and support (5.0 vs 4.0).

Value, effectiveness and user experience are within half a point.

How we score

Noom

6.9/10

Overall

StaveMD

7.7/10

Value25%

5.4A
vs
B
5.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

4.0A
vs
B
5.0

FDA warning letters

Neither Noom nor StaveMD has an FDA warning letter on record with us.

Features & Coverage

FeatureNoomStaveMD
Starting Price$179/mo$179/mo
Features2 features✓8 features
States AvailableNot disclosed51
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Noom

Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.

Read our full Noom review →

About StaveMD

StaveMD is the trading name of RZ International LLC, a California company that sells compounded GLP-1s through OpenLoop Health's clinician network and names four dispensing pharmacies. Semaglutide injections start at $179 a month, a dissolving semaglutide tablet at $199 and tirzepatide at $249, with no membership fee. Plans renew every four weeks, and a guarantee refunds every payment if you take the drug as prescribed and lose no weight.

Read our full StaveMD review →

Pros & Cons

Noom

What we like

  • Semaglutide costs $179 a month, close to the $188 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits and coaching
  • We found no FDA warning letters issued to Noom

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

StaveMD

What we like

  • Semaglutide costs $179 a month, close to the $188 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $249 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to StaveMD

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: StaveMD

StaveMD wins this one, 7.7 to 6.9, above all for compounded semaglutide or tirzepatide from named pharmacies with a no-weight-loss refund. Noom fits better if coaching bundled into the price rather than sold separately is your priority.

Choose Noom if…

You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.

Choose StaveMD if…

You want compounded semaglutide or tirzepatide from named pharmacies with a no-weight-loss refund and an opening price near $179 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.1

CoreAge Rx

Semaglutide at $99/month, 48% below the typical price

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

6.4

ShedRx

Oral orforglipron alongside the injectables

Noom vs StaveMD: FAQ

Neither on the entry price: Noom and StaveMD both start at about $179 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Noom does not publish where it ships; StaveMD lists 51 states. Confirm your state before paying.
Only Noom includes the clinician visit and coaching. Only StaveMD includes shipping.
Noom has none. StaveMD has none.
No. Neither Noom nor StaveMD pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.